4EZ7
CDK2 in complex with staurosporine and 2 molecules of 8-anilino-1-naphthalene sulfonic acid
Summary for 4EZ7
| Entry DOI | 10.2210/pdb4ez7/pdb |
| Related | 4ERW 4EZ3 |
| Descriptor | Cyclin-dependent kinase 2, STAUROSPORINE, 8-ANILINO-1-NAPHTHALENE SULFONATE, ... (5 entities in total) |
| Functional Keywords | protein kinase, ans, transferase-antibiotic complex, transferase/antibiotic |
| Biological source | Homo sapiens (human) |
| Cellular location | Cytoplasm, cytoskeleton, centrosome: P24941 |
| Total number of polymer chains | 1 |
| Total formula weight | 36074.84 |
| Authors | Alam, R.,Martin, M.P.,Zhu, J.-Y.,Schonbrunn, E. (deposition date: 2012-05-02, release date: 2012-08-22, Last modification date: 2023-09-13) |
| Primary citation | Martin, M.P.,Alam, R.,Betzi, S.,Ingles, D.J.,Zhu, J.Y.,Schonbrunn, E. A Novel Approach to the Discovery of Small-Molecule Ligands of CDK2. Chembiochem, 13:2128-2136, 2012 Cited by PubMed Abstract: In an attempt to identify novel small-molecule ligands of cyclin-dependent kinase 2 (CDK2) with potential as allosteric inhibitors, we have devised a robust and cost-effective fluorescence-based high-throughput screening assay. The assay is based on the specific interaction of CDK2 with the extrinsic fluorophore 8-anilino-1-naphthalene sulfonate (ANS), which binds to a large allosteric pocket adjacent to the ATP site. Hit compounds that displace ANS directly or indirectly from CDK2 are readily classified as ATP site binders or allosteric ligands through the use of staurosporine, which blocks the ATP site without displacing ANS. Pilot screening of 1453 compounds led to the discovery of 12 compounds with displacement activities (EC(50) values) ranging from 6 to 44 μM, all of which were classified as ATP-site-directed ligands. Four new type I inhibitor scaffolds were confirmed by X-ray crystallography. Although this small compound library contained only ATP-site-directed ligands, the application of this assay to large compound libraries has the potential to reveal previously unrecognized chemical scaffolds suitable for structure-based design of CDK2 inhibitors with new mechanisms of action. PubMed: 22893598DOI: 10.1002/cbic.201200316 PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (2.49 Å) |
Structure validation
Download full validation report
